China-based Zai Lab and American pharmaceutical firm Pfizer have announced a strategic collaboration for the novel anti-...
Laekna, Inc., a China-based biotech company focused on novel drug development for metabolic and cancer diseases, has ann...
Merck, known as MSD outside of the United States and Canada, and China-based biotech startup LaNova Medicines, have anno...
Terumo Blood and Cell Technologies (Terumo BCT), recently held a localisation launch ceremony themed 'Unlocking a ...
China-based Chime Biologics, a leading global contract development and manufacturing organisation (CDMO) that enables it...
Novotech, the global full-service clinical Contract Research Organisation (CRO) that partners with biotech companies to ...
China-based Ping An Healthcare and Technology has established a strategic partnership with Medtronic (Shanghai) Man...
With Donald Trump’s return to the White House, the U.S.-China trade relationship is once again in the spotlight. T...
Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...
Switzerland-headquartered Biosynth, a leading developer and supplier of critical raw materials and services for diagnost...
South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has secured a s...
ATLATL Hong Kong Innovation Center, a new state-of-the-art research facility designed to provide immediate, move-in-read...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...
The Hong Kong Polytechnic University (PolyU) and Sun Yat-sen University (SYSU) have signed a Memorandum of Understanding...
Shanghai Junshi Biosciences Co. and its wholly-owned subsidiary, TopAlliance Biosciences Inc., has announced that toripa...
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) and the Prince of Wales Hospital (P...
Akeso Biopharma, headquarterd in Hong Kong, has successfully raised approximately $250 million through a share plac...